Christian M. Zechmann
Heidelberg, BW 69120, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Detection Rate of 18F-Fluorethylcholine-PET/CT in relation to PSA Value in PCA Patients Referred with Biochemical Relapse.
Journal: Contrast media & molecular imaging
Published: February 24, 2020
Repeated PSMA-targeting radioligand therapy of metastatic prostate cancer with 131I-MIP-1095.
Journal: European journal of nuclear medicine and molecular imaging
Published: January 16, 2017
Increased microcirculation detected by dynamic contrast-enhanced magnetic resonance imaging is of prognostic significance in asymptomatic myeloma.
Journal: British journal of haematology
Published: November 04, 2015
Prognostic significance of increased bone marrow microcirculation in newly diagnosed multiple myeloma: results of a prospective DCE-MRI study.
Journal: European radiology
Published: April 28, 2015
Qualitative and quantitative image analysis of CT and MR imaging in patients with neuroendocrine liver metastases in comparison to (68)Ga-DOTATOC PET.
Journal: European journal of radiology
Published: April 03, 2015
Dynamic contrast-enhanced magnetic resonance imaging for assessment of antiangiogenic treatment effects in multiple myeloma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 30, 2014
The application of Gadopentate-Dimeneglumin has no impact on progression free and overall survival as well as renal function in patients with monoclonal plasma cell disorders if general precautions are taken.
Journal: European radiology
Published: April 21, 2014
Radiation dosimetry and first therapy results with a (124)I/ (131)I-labeled small molecule (MIP-1095) targeting PSMA for prostate cancer therapy.
Journal: European journal of nuclear medicine and molecular imaging
Published: October 02, 2013
Contrast-enhanced ultrasound monitoring of perfusion changes in hepatic neuroendocrine metastases after systemic versus selective arterial 177Lu/90Y-DOTATOC and 213Bi-DOTATOC radiopeptide therapy.
Journal: Experimental oncology
Published: July 06, 2013
Comparison of PET imaging with a (68)Ga-labelled PSMA ligand and (18)F-choline-based PET/CT for the diagnosis of recurrent prostate cancer.
Journal: European journal of nuclear medicine and molecular imaging
Published: May 10, 2013
Assessment of diffusion-weighted MRI and 18F-fluoro-deoxyglucose PET/CT in monitoring early response to neoadjuvant chemotherapy in adenocarcinoma of the esophagogastric junction.
Journal: Journal of gastrointestinal and liver diseases : JGLD
Published: March 30, 2013
Last Updated: 09/26/2026